{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T23:43:34Z","timestamp":1791848614842,"version":"4.3.4"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T00:00:00Z","timestamp":1778803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T00:00:00Z","timestamp":1778803200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Differ"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Follicular lymphoma (FL) is one of the most common types of indolent non-Hodgkin lymphoma that can undergo rapid progression, which is associated with poor patient outcomes. The homing of B cells into aberrant immunological niches within the germinal center (GC) is a prerequisite for disease development. The C-C chemokine receptor type 7 (\n                    <jats:italic>CCR7<\/jats:italic>\n                    ), expressed by circulating B cells, mediates their homing and dissemination to draining lymph nodes (drLNs). Here, we identified activated B cells emerging from adjacent GCs in drLNs as the origin of circulating memory B cells in distant LNs. Transcriptional upregulation of\n                    <jats:italic>Ccr7<\/jats:italic>\n                    in these memory B cells was found to guide their migration. To model lymphomagenesis, we generated a mouse model with B-cell-specific\n                    <jats:italic>Myc<\/jats:italic>\n                    overexpression, achieved by CRISPR\/Cas9-mediated homologous recombination to insert a\n                    <jats:italic>Myc<\/jats:italic>\n                    expression cassette into the Hipp11 locus. Histological signs of aggressive lymphoma were evident in\n                    <jats:italic>Ccr7<\/jats:italic>\n                    wild-type mice, whereas\n                    <jats:italic>Ccr7<\/jats:italic>\n                    knockout mice exhibited pre-malignant atypia phenotypes. We in-depth revealed that\n                    <jats:italic>Ccr7<\/jats:italic>\n                    knockout impeded the differentiation of pre-malignant Rnaseh2a+ memory B cells toward malignant Pax5+ GC B cells. Furthermore,\n                    <jats:italic>Ccr7<\/jats:italic>\n                    deficiency attenuated the dependency of malignant memory or GC B cells on extensive follicular dendritic cell (FDC) networks and T-cell help. Conversely, IL-1\u03b2-induced FDC re-expansion preferentially fostered the proliferation of malignant GC B cells even in the context of\n                    <jats:italic>Ccr7<\/jats:italic>\n                    knockout. Our findings reveal an unforeseen role for\n                    <jats:italic>CCR7<\/jats:italic>\n                    in driving the malignant evolution of memory B cells by orchestrating their migratory dynamics and reprogramming the supportive GC niche.\n                  <\/jats:p>","DOI":"10.1038\/s41418-026-01758-x","type":"journal-article","created":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T14:55:54Z","timestamp":1778856954000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["CCR7 orchestrates the malignant progression of memory B cells in MYC-overexpressing lymphoma"],"prefix":"10.1038","author":[{"given":"Yuwei","family":"Deng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenyuan","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Qin","family":"Mu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiyou","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8116-5293","authenticated-orcid":false,"given":"Qingyuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-0362-7075","authenticated-orcid":false,"given":"Jianli","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,15]]},"reference":[{"key":"1758_CR1","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.ccell.2020.04.004","volume":"37","author":"W B\u00e9guelin","year":"2020","unstructured":"B\u00e9guelin W, Teater M, Meydan C, Hoehn KB, Phillip JM, Soshnev AA, et al. Mutant EZH2 induces a pre-malignant lymphoma niche by reprogramming the immune response. Cancer Cell. 2020;37:655\u201373.e11.","journal-title":"Cancer Cell"},{"key":"1758_CR2","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.cell.2020.05.049","volume":"182","author":"L Venturutti","year":"2020","unstructured":"Venturutti L, Teater M, Zhai A, Chadburn A, Babiker L, Kim D, et al. TBL1XR1 mutations drive extranodal lymphoma by inducing a pro-tumorigenic memory fate. Cell. 2020;182:297\u2013316.e27.","journal-title":"Cell"},{"key":"1758_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-021-00525-0","volume":"11","author":"K Arushi","year":"2021","unstructured":"Arushi K, Mwangi R, Ansell SM, Habermann TM, Cerhan JR, Strouse C, et al. Patterns of therapy initiation during the first decade for patients with follicular lymphoma who were observed at diagnosis in the rituximab era. Blood cancer J. 2021;11:133.","journal-title":"Blood cancer J"},{"key":"1758_CR4","doi-asserted-by":"publisher","first-page":"2804","DOI":"10.1182\/blood-2015-11-632745","volume":"127","author":"JO Armitage","year":"2016","unstructured":"Armitage JO, Longo DL. Is watch and wait still acceptable for patients with low-grade follicular lymphoma? Blood. 2016;127:2804\u20138.","journal-title":"Blood"},{"key":"1758_CR5","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1016\/j.ccell.2024.05.011","volume":"42","author":"C Sarkozy","year":"2024","unstructured":"Sarkozy C, Wu S, Takata K, Aoki T, Neriah SB, Milne K, et al. Integrated single cell analysis reveals co-evolution of malignant B cells and tumor micro-environment in transformed follicular lymphoma. Cancer Cell. 2024;42:1003\u201317.e6.","journal-title":"Cancer Cell"},{"key":"1758_CR6","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1182\/blood.2019000258","volume":"134","author":"CL Freeman","year":"2019","unstructured":"Freeman CL, Kridel R, Moccia AA, Savage KJ, Villa DR, Scott DW, et al. Early progression after bendamustine-rituximab is associated with high risk of transformation in advanced stage follicular lymphoma. Blood. 2019;134:761\u20134.","journal-title":"Blood"},{"key":"1758_CR7","doi-asserted-by":"crossref","unstructured":"Araujo-Ayala F, B\u00e9guelin W. Biology as vulnerability in follicular lymphoma: genetics, epigenetics, and immunogenetics. Blood. 2025;146:1759\u201369.","DOI":"10.1182\/blood.2024026020"},{"key":"1758_CR8","doi-asserted-by":"publisher","first-page":"2160","DOI":"10.1038\/s41588-023-01561-1","volume":"55","author":"RJ Leeman-Neill","year":"2023","unstructured":"Leeman-Neill RJ, Song D, Bizarro J, Wacheul L, Rothschild G, Singh S, et al. Noncoding mutations cause super-enhancer retargeting resulting in protein synthesis dysregulation during B cell lymphoma progression. Nat Genet. 2023;55:2160\u201374.","journal-title":"Nat Genet"},{"key":"1758_CR9","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.1038\/s41591-022-01959-0","volume":"28","author":"NJ Haradhvala","year":"2022","unstructured":"Haradhvala NJ, Leick MB, Maurer K, Gohil SH, Larson RC, Yao N, et al. Distinct cellular dynamics associated with response to CAR-T therapy for refractory B cell lymphoma. Nat Med. 2022;28:1848\u201359.","journal-title":"Nat Med"},{"key":"1758_CR10","doi-asserted-by":"crossref","unstructured":"Mulvey E, Rutherford SC, Leonard JP. The future of follicular lymphoma management: strategies on the horizon. Blood. 2025;146:1792\u2013801.","DOI":"10.1182\/blood.2024026017"},{"key":"1758_CR11","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1182\/blood.2023021000","volume":"143","author":"C Laurent","year":"2024","unstructured":"Laurent C, Dietrich S, Tarte K. Cell cross talk within the lymphoma tumor microenvironment: follicular lymphoma as a paradigm. Blood. 2024;143:1080\u201390.","journal-title":"Blood"},{"key":"1758_CR12","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adl3975","volume":"10","author":"C Schulthei\u00df","year":"2024","unstructured":"Schulthei\u00df C, Paschold L, Mohebiany AN, Escher M, Kattimani YM, M\u00fcller M, et al. A20 haploinsufficiency disturbs immune homeostasis and drives the transformation of lymphocytes with permissive antigen receptors. Sci Adv. 2024;10:eadl3975.","journal-title":"Sci Adv"},{"key":"1758_CR13","doi-asserted-by":"crossref","unstructured":"Wang J, Tao Q, Huang K, Wang Y, Hu L, Ren A, et al. Chemotherapy-induced cellular senescence promotes stemness of aggressive B-cell non-Hodgkin\u2019s lymphoma via CCR7\/ARHGAP18\/IKB\u03b1 signaling activation. J Immunotherapy Cancer. 2025;13:e009356.","DOI":"10.1136\/jitc-2024-009356"},{"key":"1758_CR14","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1182\/blood-2010-11-321265","volume":"118","author":"A Rehm","year":"2011","unstructured":"Rehm A, Mensen A, Schradi K, Gerlach K, Wittstock S, Winter S, et al. Cooperative function of CCR7 and lymphotoxin in the formation of a lymphoma-permissive niche within murine secondary lymphoid organs. Blood. 2011;118:1020\u201333.","journal-title":"Blood"},{"key":"1758_CR15","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1038\/s41590-021-00920-6","volume":"22","author":"VN Kapoor","year":"2021","unstructured":"Kapoor VN, M\u00fcller S, Keerthivasan S, Brown M, Chalouni C, Storm EE, et al. Gremlin 1(+) fibroblastic niche maintains dendritic cell homeostasis in lymphoid tissues. Nat Immunol. 2021;22:571\u201385.","journal-title":"Nat Immunol"},{"key":"1758_CR16","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/s41392-023-01659-2","volume":"8","author":"Y Wang","year":"2023","unstructured":"Wang Y, Tong C, Lu Y, Wu Z, Guo Y, Liu Y, et al. Characteristics of premanufacture CD8(+)T cells determine CAR-T efficacy in patients with diffuse large B-cell lymphoma. Signal Transduct Target Ther. 2023;8:409.","journal-title":"Signal Transduct Target Ther"},{"key":"1758_CR17","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abo3826","volume":"15","author":"C Mastini","year":"2023","unstructured":"Mastini C, Campisi M, Patrucco E, Mura G, Ferreira A, Costa C, et al. Targeting CCR7-PI3K\u03b3 overcomes resistance to tyrosine kinase inhibitors in ALK-rearranged lymphoma. Sci Transl Med. 2023;15:eabo3826.","journal-title":"Sci Transl Med"},{"key":"1758_CR18","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1016\/j.cell.2022.01.018","volume":"185","author":"K R\u00f6ltgen","year":"2022","unstructured":"R\u00f6ltgen K, Nielsen SCA, Silva O, Younes SF, Zaslavsky M, Costales C, et al. Immune imprinting, breadth of variant recognition, and germinal center response in human SARS-CoV-2 infection and vaccination. Cell. 2022;185:1025\u201340.e14.","journal-title":"Cell"},{"key":"1758_CR19","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.ado0090","volume":"9","author":"F Cossarini","year":"2024","unstructured":"Cossarini F, Shang J, Krek A, Al-Taie Z, Hou R, Canales-Herrerias P, et al. Gastrointestinal germinal center B cell depletion and reduction in IgA(+) plasma cells in HIV-1 infection. Sci Immunol. 2024;9:eado0090.","journal-title":"Sci Immunol"},{"key":"1758_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-29978-y","volume":"13","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Garcia-Ibanez L, Ulbricht C, Lok LSC, Pike JA, Mueller-Winkler J, et al. Recycling of memory B cells between germinal center and lymph node subcapsular sinus supports affinity maturation to antigenic drift. Nat Commun. 2022;13:2460.","journal-title":"Nat Commun"},{"key":"1758_CR21","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1182\/blood.2024024251","volume":"144","author":"LK Hilton","year":"2024","unstructured":"Hilton LK, Collinge B, Ben-Neriah S, Alduaij W, Shaalan H, Weng AP, et al. Motive and opportunity: MYC rearrangements in high-grade B-cell lymphoma with MYC and BCL2 rearrangements (an LLMPP study). Blood. 2024;144:525\u201340.","journal-title":"Blood"},{"key":"1758_CR22","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.ccell.2024.02.010","volume":"42","author":"D Barisic","year":"2024","unstructured":"Barisic D, Chin CR, Meydan C, Teater M, Tsialta I, Mlynarczyk C, et al. ARID1A orchestrates SWI\/SNF-mediated sequential binding of transcription factors with ARID1A loss driving pre-memory B cell fate and lymphomagenesis. Cancer Cell. 2024;42:583\u2013604.e11.","journal-title":"Cancer Cell"},{"key":"1758_CR23","doi-asserted-by":"publisher","first-page":"2739","DOI":"10.1038\/s41588-024-02019-8","volume":"56","author":"C Tian","year":"2024","unstructured":"Tian C, Zhang Y, Tong Y, Kock KH, Sim DY, Liu F, et al. Single-cell RNA sequencing of peripheral blood links cell-type-specific regulation of splicing to autoimmune and inflammatory diseases. Nat Genet. 2024;56:2739\u201352.","journal-title":"Nat Genet"},{"key":"1758_CR24","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1038\/s41590-024-01900-2","volume":"25","author":"W Shao","year":"2024","unstructured":"Shao W, Wang Y, Fang Q, Shi W, Qi H. Epigenetic recording of stimulation history reveals BLIMP1-BACH2 balance in determining memory B cell fate upon recall challenge. Nat Immunol. 2024;25:1432\u201344.","journal-title":"Nat Immunol"},{"key":"1758_CR25","doi-asserted-by":"publisher","first-page":"2635","DOI":"10.1038\/s41375-021-01201-9","volume":"35","author":"JG Valero","year":"2021","unstructured":"Valero JG, Matas-C\u00e9spedes A, Arenas F, Rodriguez V, Carreras J, Serrat N, et al. The receptor of the colony-stimulating factor-1 (CSF-1R) is a novel prognostic factor and therapeutic target in follicular lymphoma. Leukemia. 2021;35:2635\u201349.","journal-title":"Leukemia"},{"key":"1758_CR26","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1038\/s41590-023-01503-3","volume":"24","author":"M L\u00fctge","year":"2023","unstructured":"L\u00fctge M, De Martin A, Gil-Cruz C, Perez-Shibayama C, Stanossek Y, Onder L, et al. Conserved stromal-immune cell circuits secure B cell homeostasis and function. Nat Immunol. 2023;24:1149\u201360.","journal-title":"Nat Immunol"},{"key":"1758_CR27","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1111\/imr.12860","volume":"296","author":"MA Mintz","year":"2020","unstructured":"Mintz MA, Cyster JG. T follicular helper cells in germinal center B cell selection and lymphomagenesis. Immunol Rev. 2020;296:48\u201361.","journal-title":"Immunol Rev"},{"key":"1758_CR28","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1038\/s41577-022-00829-7","volume":"23","author":"FT Liu","year":"2023","unstructured":"Liu FT, Stowell SR. The role of galectins in immunity and infection. Nat Rev Immunol. 2023;23:479\u201394.","journal-title":"Nat Rev Immunol"},{"key":"1758_CR29","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1182\/blood.2024026664","volume":"146","author":"H Yang","year":"2025","unstructured":"Yang H, Zhang W, Ravanmehr V, Cui G, Bowman K, Chen R, et al. Blunted CD40-responsive enhancer activation in CREBBP-mutant lymphomas can be restored by enforced CD4 T-cell engagement. Blood. 2025;146:191\u2013205.","journal-title":"Blood"},{"key":"1758_CR30","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1016\/j.cell.2019.07.028","volume":"178","author":"K Jaeger","year":"2019","unstructured":"Jaeger K, Bruenle S, Weinert T, Guba W, Muehle J, Miyazaki T, et al. Structural basis for allosteric ligand recognition in the human CC chemokine receptor 7. Cell. 2019;178:1222\u201330.e10.","journal-title":"Cell"},{"key":"1758_CR31","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1016\/j.cell.2024.11.031","volume":"188","author":"KY Chen","year":"2025","unstructured":"Chen KY, De Giovanni M, Xu Y, An J, Kirthivasan N, Lu E, et al. Inflammation switches the chemoattractant requirements for naive lymphocyte entry into lymph nodes. Cell. 2025;188:1019\u201335.e22.","journal-title":"Cell"},{"key":"1758_CR32","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.ccell.2024.02.001","volume":"42","author":"AJ Radtke","year":"2024","unstructured":"Radtke AJ, Postovalova E, Varlamova A, Bagaev A, Sorokina M, Kudryashova O, et al. Multi-omic profiling of follicular lymphoma reveals changes in tissue architecture and enhanced stromal remodeling in high-risk patients. Cancer Cell. 2024;42:444\u201363.e10.","journal-title":"Cancer Cell"},{"key":"1758_CR33","doi-asserted-by":"crossref","unstructured":"Murase W, Kamakura Y, Kawakami S, Yasuda A, Wagatsuma M, Kubota A, et al. Fucoxanthin prevents pancreatic tumorigenesis in C57BL\/6J mice that received allogenic and orthotopic transplants of cancer cells. Int J Mol Sci. 2021;22:13620.","DOI":"10.3390\/ijms222413620"},{"key":"1758_CR34","doi-asserted-by":"publisher","first-page":"2256","DOI":"10.1016\/j.immuni.2021.08.028","volume":"54","author":"L Duan","year":"2021","unstructured":"Duan L, Liu D, Chen H, Mintz MA, Chou MY, Kotov DI, et al. Follicular dendritic cells restrict interleukin-4 availability in germinal centers and foster memory B cell generation. Immunity. 2021;54:2256\u201372.e6.","journal-title":"Immunity"},{"key":"1758_CR35","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1016\/j.immuni.2021.07.018","volume":"54","author":"F Mourcin","year":"2021","unstructured":"Mourcin F, Verdi\u00e9re L, Roulois D, Amin R, Lamaison C, Sibut V, et al. Follicular lymphoma triggers phenotypic and functional remodeling of the human lymphoid stromal cell landscape. Immunity. 2021;54:1901.","journal-title":"Immunity"},{"key":"1758_CR36","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/s41586-024-07134-4","volume":"627","author":"S Nakandakari-Higa","year":"2024","unstructured":"Nakandakari-Higa S, Walker S, Canesso MCC, van der Heide V, Chudnovskiy A, Kim DY, et al. Universal recording of immune cell interactions in vivo. Nature. 2024;627:399\u2013406.","journal-title":"Nature"},{"key":"1758_CR37","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1002\/cac2.12241","volume":"42","author":"N Wang","year":"2022","unstructured":"Wang N, Qin W, Zheng Z, Zhao M, Xiong J, Fang H, et al. Hepatitis B virus-associated follicular lymphoma presents T-cell inflamed phenotype and response to lenalidomide. Cancer Commun. 2022;42:170\u20134.","journal-title":"Cancer Commun"},{"key":"1758_CR38","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1016\/S1470-2045(24)00263-8","volume":"25","author":"JL Van Laethem","year":"2024","unstructured":"Van Laethem JL, Borbath I, Prenen H, Geboes KP, Lambert A, Mitry E, et al. Combining CD40 agonist mitazalimab with mFOLFIRINOX in previously untreated metastatic pancreatic ductal adenocarcinoma (OPTIMIZE-1): a single-arm, multicentre phase 1b\/2 study. Lancet Oncol. 2024;25:853\u201364.","journal-title":"Lancet Oncol"}],"container-title":["Cell Death &amp; Differentiation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41418-026-01758-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41418-026-01758-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41418-026-01758-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T14:55:56Z","timestamp":1778856956000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41418-026-01758-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,15]]},"references-count":38,"alternative-id":["1758"],"URL":"https:\/\/doi.org\/10.1038\/s41418-026-01758-x","relation":{},"ISSN":["1350-9047","1476-5403"],"issn-type":[{"value":"1350-9047","type":"print"},{"value":"1476-5403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,15]]},"assertion":[{"value":"21 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The experimental procedures were performed in strict accordance with the institutional guidelines delineated by Harbin Medical University, the Guide for the Care and Use of Laboratory Animals, and standards established by the Association for Assessment and Accreditation of Laboratory Animal Care International. The Southern Model Biology Research Center (Shanghai), the Institutional Animal Care and Use Committee of Harbin Medical University, and Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences, vetted all procedures and duly approved the entirety of the study involving mice under institutional Review Boards #HMUIRB2025004 and protocols #SCXK(shanghai)2019-0002. All study procedures for human samples were approved by the Institutional Review Boards (IRBs) of Harbin Medical University Cancer (approval no. KY2023-79). Written informed consent was obtained from all participating patients. This study was conducted in accordance with the principles of the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}